TABLE 3.
Region and country (setting, period of study) | Prevalence (%) of serotype: |
Reference | |||||||
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||
North Africa | |||||||||
Egypt (rural, 1995–1998) | 43.3 | 3.6 | 12.0 | 4.8 | 15.7 | 7.2 | 0 | 12.0 | 237 |
Asia | |||||||||
Vietnam (urban, 2005–2006) | 100.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 241 |
India (urban, 2004–2008) | 6707 | 9.7 | 0 | 0 | 6.5a | 0 | 0 | 16.0 | 308 |
Japan (urban 2008–2009) | 91.0 | 0 | 9.0 | 0 | 0 | 0 | 0 | 0 | 250 |
North America | |||||||||
USA (urban, 1993–1994) | 55.0 | 17.0 | —b | — | — | — | — | — | 266 |
South America | |||||||||
Brazil (urban, 1990–1992) | 45.5 | 27.3 | 12.1 | 12.1 | 0 | 3.0 | 0 | 0 | 265 |
Argentina (urban, 1995–1998) | 41.0 | 13.0 | 13.0 | 25.0 | 8.0 | 0 | 0 | 0 | 267 |
Europe | |||||||||
Spain (urban, 1997–2000) | 38.0 | 6.0 | 19.0 | 26.0 | 0 | 0 | 0 | 11.0 | 164 |
Oceania | |||||||||
Australia (urban, 1995) | 85.0 | 0 | 0 | 15.0 | 0 | 0 | 0 | 0 | 35 |
ORF1a/ORF2 recombinant strains.
—, there were no data on this genotype in the study.